Gillian Murphy
- Cancer Research top 0.01%
- Protease and Inhibitor Mechanisms 239
- Immunology and Allergy top 0.01%
- Cell Adhesion Molecules Research 80
- Hematology top 0.05%
- Blood Coagulation and Thrombosis Mechanisms 87
- Oncology top 0.05%
- Peptidase Inhibition and Analysis 140
- HER2/EGFR in Cancer Research 19
- Rheumatology top 0.1%
-
- Signaling Pathways in Disease 44
-
- Connective tissue disorders research 17
-
- Enzyme Production and Characterization 16
- Co-authors
- Vera KnäuperAndrew DochertyJohn J. ReynoldsSusan J. AtkinsonDylan R. EdwardsFrances WillenbrockCarlos López-Otı́nAndrew H. Baker
- Journals
- Journal of Biological Chemistry (58 papers)Biochemical Journal (42 papers)FEBS Letters (19 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Gillian Murphy
313 papers receiving 36.8k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Cancer Research 21.3k
- Immunology and Allergy 7.0k
- Hematology 7.5k
- Oncology 14.2k
- Rheumatology 4.1k
Countries citing papers authored by Gillian Murphy
This map shows the geographic impact of Gillian Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Murphy more than expected).
Fields of papers citing papers by Gillian Murphy
This network shows the impact of papers produced by Gillian Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Murphy. The network helps show where Gillian Murphy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gillian Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 19 | |
| 2 | 2020 | 25 | |
| 3 | 2017 | 7 | |
| 4 | 2014 | 68 | |
| 5 | 2005 | 54 | |
| 6 | 2005 | 23 | |
| 7 | 2004 | 17 | |
| 8 | 2004 | 134 | |
| 9 | 2004 | 114 | |
| 10 | 2002 | 29 | |
| 11 | 2001 | 96 | |
| 12 | 2001 | 40 | |
| 13 | 2001 | 53 | |
| 14 | 1996 | 75 | |
| 15 | 1995 | 220 | |
| 16 | HUMAN TUMOR-ASSOCIATED TRYPSIN(OGEN)-2 ACTIVATES 3 GENETICALLY DISTINCT BUT STRUCTURALLY HOMOLOGOUS HUMAN PRO-MATRIX METALLOPROTEINASES | 1994 | 1 |
| 17 | 1994 | 83 | |
| 18 | 1994 | 84 | |
| 19 | 1993 | 63 | |
| 20 | 1990 | 85 |
About Gillian Murphy
Gillian Murphy is a scholar working on Cancer Research, Immunology and Allergy and Hematology, having authored 314 papers that have together received 38.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (239 papers), Peptidase Inhibition and Analysis (140 papers), Blood Coagulation and Thrombosis Mechanisms (87 papers), Cell Adhesion Molecules Research (80 papers), Signaling Pathways in Disease (44 papers), HER2/EGFR in Cancer Research (19 papers), Connective tissue disorders research (17 papers) and Enzyme Production and Characterization (16 papers). The work is most often cited by research in Cancer Research (21.3k citations), Immunology and Allergy (7.0k citations) and Hematology (7.5k citations). Gillian Murphy has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Vera Knäuper, Andrew Docherty, John J. Reynolds, Susan J. Atkinson, Dylan R. Edwards, Frances Willenbrock, Carlos López-Otı́n, Andrew H. Baker, Rosalind M. Hembry and Bryan Ronain Smith. Their work appears in journals such as Journal of Biological Chemistry, Biochemical Journal, FEBS Letters, Journal of Cell Science and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.